Join the club for FREE to access the whole archive and other member benefits.

Small molecule oral drug could treat influenza A

11-Mar-2019

Key points from article :

Scripps Research has discovered an drug that neutralizes influenza A group 1 viruses.

Covers many of the seasonal flu strains, and also pandemic strains, such as H1N1 and H5N1.

JNJ-4796 is an orally active small molecule drug.

Recognizes the HA stem in the same way as the antibody.

Protected mice infected with 25 times the normally-lethal dose of H1N1 influenza.

Small molecules are cheaper, more shelf-stable, and are more convenient for patients.

The study was published in Science journal.

Targets seasonal and pandemic strains of flu

Mentioned in this article:

Tap on icon for description, click on resource name for more details.

Academic

Hansen Professor of Structural Biology at Scripps Research Institute.

Company

Pharmaceutical company which is part of Johnson & Johnson company.

Journal

Peer-reviewed academic online journal of the American Association for the Advancement of Science (AAAS)

Institute

Medical research facility with focus on research and education in the biomedical sciences.